ARS Pharmaceuticals, Inc.

General ticker "SPRY" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $1.3B (TTM average)

ARS Pharmaceuticals, Inc. does not follow the US Stock Market performance with the rate: -9.9%.

Estimated limits based on current volatility of 2.2%: low 9.92$, high 10.36$

Factors to consider:

  • Total employees count: 90 as of 2021
  • Price in estimated range
  • Earnings for 9 months up through Q3 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [5.14$, 15.21$]
  • 2025-12-31 to 2026-12-31 estimated range: [3.61$, 11.25$]

Financial Metrics affecting the SPRY estimates:

  • Positive: with PPE of 137.8 at the end of fiscal year the price was low
  • Positive: -5.04 < Operating profit margin, % of -3.34
  • Negative: Inventory ratio change, % of 4.96 > 0.79
  • Negative: Investing cash flow per share per price, % of -9.93 <= -4.43
  • Negative: Operating cash flow per share per price, % of 1.27 <= 6.66
  • Positive: Interest expense per share per price, % of 0 <= 0.01
  • Negative: negative Industry operating cash flow (median)
  • Negative: Shareholder equity ratio, % of 73.13 > 64.37
  • Negative: Industry earnings per price (median), % of -16.05 <= 0

Similar symbols

Short-term SPRY quotes

Long-term SPRY plot with estimates

Financial data

YTD 2022-12-31 2023-12-31 2024-12-31
Operating Revenue $1.32MM $0.03MM $89.15MM
Operating Expenses $36.83MM $67.55MM $92.23MM
Operating Income $-35.52MM $-67.52MM $-3.08MM
Non-Operating Income $0.83MM $13.15MM $11.37MM
R&D Expense $18.38MM $20.27MM $19.58MM
Income(Loss) $-34.68MM $-54.37MM $8.29MM
Taxes $0.00MM $0.00MM $0.29MM
Profit(Loss)* $-34.68MM $-54.37MM $8.00MM
Stockholders Equity $272.89MM $230.76MM $256.80MM
Inventory $0.00MM $0.00MM $5.21MM
Assets $281.44MM $233.19MM $351.15MM
Operating Cash Flow $-40.08MM $-59.27MM $13.55MM
Capital expenditure $0.20MM $0.17MM $0.56MM
Investing Cash Flow $-0.20MM $-87.18MM $-106.10MM
Financing Cash Flow $190.73MM $6.90MM $72.40MM
Earnings Per Share** $-0.87 $-0.57 $0.08

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.